Takeda Heterocyclic Compound Patent EP3919055A1

The European Patent Office published Takeda Pharmaceutical Company Limited's patent application EP3919055A1 for heterocyclic compounds. The patent covers novel chemical compositions with potential therapeutic applications in neurological and neurodegenerative disease treatment. Publication Kind A1 indicates the application includes search report.

Solid Forms of Triazolo-pyrimidine Compound Patent

The European Patent Office published Novartis AG's patent application EP3864018A1 covering solid forms of a triazolo-pyrimidine compound (N-(4-Fluoro-3-(6-(3-methylpyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)phenyl)-2,4-dimethyloxazole-5-carboxamide). The patent designates 32 European states. This is a routine patent publication in the EPO Organic Chemistry bulletin.

Heterocyclic Sulfonamide Derivatives and Pharmaceutical Uses Thereof

The European Patent Office published patent EP3817742A1 for Temmune Therapeutics NV covering heterocyclic sulfonamide derivatives and their pharmaceutical applications. The patent, filed by nine inventors, covers therapeutic uses including cardiovascular, neurological, anti-inflammatory, and immunological conditions. The patent is designated across 31 European contracting states.

Incyte patents fused pyrimidines, A2A/A2B inhibitors, EP3810610A1

Incyte patents fused pyrimidines, A2A/A2B inhibitors, EP3810610A1

Lithuania and Monaco local democracy recommendations adopted

Lithuania and Monaco local democracy recommendations adopted

F. Hoffmann-La Roche AG - Plunger and Method of Manufacturing a Plunger

The European Patent Office published Patent EP3820551A1 granting F. Hoffmann-La Roche AG rights to a plunger device and its method of manufacture. The patent covers IPC classification A61M 5/315 and is valid in all designated Contracting States. No regulatory compliance actions or deadlines are associated with this patent grant.

Microneedle Device Patent EP3795358A1

The European Patent Office granted Axenoll Life Sciences AG Patent EP3795358A1 for a microneedle device and manufacturing method. The patent covers innovations in microneedle technology for transdermal drug delivery applications. Inventors include Vasic, Srdan and Schmitt, Rafael.

Medtronic Xomed Valve Adjustment Apparatus Patent

The European Patent Office published patent application EP3672676A1 for Medtronic Xomed, Inc., covering an apparatus for valve adjustment. Invented by W. Jeffrey Bertrand, the patent is classified under A61M 27/00 and designates 31 European states including all EU member states. Patent publication is an informational notice creating no regulatory obligations.

Multi-Use Drug Delivery Device for Drugs with Less Preservatives

The European Patent Office published patent application EP3675934A1 by Novo Nordisk A/S for a multi-use drug delivery device designed for drugs containing fewer preservatives. The application covers injection devices with features for improved preservation and was published March 25, 2026. This publication does not constitute a granted patent and imposes no compliance obligations on third parties.

Aerosol Delivery Device and Related Method - Patent EP3599912A2

The European Patent Office published patent application EP3599912A2 for RAI Strategic Holdings, Inc., covering an aerosol delivery device and related method. The patent application was published March 25, 2026, with inventors Eric M. Sparklin, Sawyer A. Hubbard, Karen V. Taluskie, and Stephen Benson Sears. The application is designated for 38 European member states.